On November 5, 2020 the medicinal product was officially included in the List of Prequalified Medicinal Products by the World Health Organization (WHO)
Prequalification of medicinal products is a procedure performed by the WHO to assess the quality, safety and efficacy of medicinal products.
The inclusion of the medicinal product in the List of Prequalified Medicinal Products opens up opportunities for Farmak to participate in procurements conducted by international procurement organizations for the needs of the planet population.
Dexamethasone phosphate, except for its main area of intended use, was also included in the list of medicinal products used in the treatment of complications caused by COVID-19.
During the prequalification, the Company underwent the process from the product pharmaceutical development and registration dossier formation to inspection of manufacturing sites by WHO experts.
Farmak Executive Director Volodymyr Kostiuk and Rector of Taras Shevchenko National University of Kyiv Volodymyr Bugrov signed a Memorandum of Cooperation between a pharmaceutical company and a leading university in the country. The purpose of the Memorandum is to improve the quality of education of specialists preparing at the university in the field of med...
In early March, the European Congress of Radiology was held in the capital of Austria. The delegation of the Farmak company took part in the event and presented to the international community a stand with three contrast drugs of its own production. ECR is one of the largest medical events in Europe and the second-largest […]
Farmak won the TOP-25 rating of employers open to cooperation with young people, according to STUD-POINT. The rating assessed the activities of more than 500 Ukrainian companies. The main criterion for determining the winners was the openness of businesses to students and the availability of effective projects designed to develop young professionals and thei...